US Patent Issued to Children's Medical Center on April 22 for "Compositions and methods for delivering nucleic acids to cochlear and vestibular cells" (Swiss, American Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,313, issued on April 22, was assigned to Children's Medical Center Corp. (Boston).

"Compositions and methods for delivering nucleic acids to cochlear and vestibular cells" was invented by Jeffrey R. Holt (Boston), Yukako Asai (Boston), Paola Andrea Solanes Vega (Lausanne, Switzerland) and Bernard Schneider (Lausanne, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are materials and methods for efficiently delivering nucleic acids to cochlear and vestibular cells, and methods of treating sensory transduction disorders associated with a genetic defect."

The patent was filed on Sept. 2, 2020, under Application No. 17/010,556....